HuntDiseaseFAQS

Retest effects and cognitive decline in early HD.
Home
Index
GENETIC TESTING INFO
EARLY HD
MEDICATIONS~DRUGS
Movement Disorder Medicines
Anxiety-Antidepressant Medications
Antidepressant Adverse Effects
Warnings~Adolescents Under 25
Sertraline ~Zoloft
SSRI's
Anti-psychotic Medications
Prozac, Luvox, Paxil, Zoloft & Celexa
Olanzipine & Risperidone and blood tests
Creatine
Drugs~General
Cutting Prescriptions
Sites That Help the Medicine Go Down
Vitamins & Minerals
SYMPTOMS
Why Certain Symptoms Occur In HD
Tests Commonly Used -Neuropsychological Examination
Symptom vs Medication
HD-Disability
HD~Communications
Speech & Swallowing Difficulties~Lynn Rhodes
Swallowing Problem Warning Signs
Swallowing Tests
Nutrition and HD~Anna Gaba (Recipes)
HD & Diet~HSA Fact Sheet 7
HD~Swallowing & Nutrition
Weight Gain
Taste
5 Levels Difficulty In Swallowing
Feeding Tube~Advanced Stages of HD
Feeding Tube~Jean Miller
One more word on feeding tubes
PEG Tubes and baby foods
Feeding Tubes-More Info
Dehydration
HD~Chorea
HD~Falling/Safety Issues
HD~Cognitive/Decision Making/Impulsivity
Cognitive-Short Tips
HD-Apathy
HD~Perceptual/Unawareness/Attention
Denial of HD
HD~Irritability/Temper Outbursts
Managing behavioral problems
HD~Depression
Depression - Treatment Resistant Patient
HD~Anxiety/Apathy/Irritability
HD~Mania, Obsessive Disorders
HD~Hallucinations & Psychosis
HD~Rigidity, Spasticity, and Dystonia
HD~Seizure/Convulsion/Epilepsy/Tics
Nails
MISCELLANEOUS
Adaptive Products
HD~Suicide
Teen Suicide~Let's Talk Facts
HD~Incontinence
Stress Explained-Easy/Fun Format
How To Help Someone Chronically Ill
Legal Planning for Incapacity
Out-of-Home Care Options FAQ
Preparing for Emergencies
 Retest effects and cognitive decline in early HD.
 OBJECTIVE:
To assess the natural progression of cognitive impairment in Huntington's disease (HD) and to reveal factors that may mask this progression.

BACKGROUND:
Although numerous cross-sectional studies reported cognitive deterioration at different stages of the disease, progressive cognitive deterioration has been, up to now, difficult to demonstrate in neuropsychological longi-tudinal studies.

METHODS:
The authors assessed 22 patients in early stages of HD at yearly intervals for 2 to 4 years (average, 31.2 +/- 10 months), using a comprehensive neuropsychological battery based on the Core Assessment Program for
Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).


RESULTS:
The authors observed a significant decline in different cognitive functions over time: these involved primarily attention and executive functions but also involved language comprehension, and visuospatial immediate memory.
Episodic memory impairment that was already present at the time of enrollment
did not show significant decline. The authors found a significant retest effect at the second assessment in many tasks.
 
CONCLUSION:
Many attention and executive tasks adequately assess the progression of the disease at an early stage. For other functions, the overlapping of retest effects and disease progression may confuse the results. High interindividual and intraindividual variability seem to be hallmarks of the disease.

Source: Medscape
Neurology 2001 Apr 24;56(8):1052-8   (ISSN: 0028-3878) Bachoud-Levi AC; Maison P; Bartolomeo P; Boisse MF; Dalla Barba G;Ergis AM; Baudic S; Degos JD; Cesaro P; Peschanski M Departement de Neurosciences Medicales, CHU Henri Mondor, Creteil, France. bachoud@lscp.ehess.fr